Overall, our results demonstrated that SIN inhibited TGF-β1/Smad3, PI3K/Akt, and NF-κB pathways to produce its therapeutic effects on PF (Fig. 9). This evidence concerns the gene SMAD3 and pemphigus foliaceus.